title: [Bisphosphonates-related jaw osteonecrosis].
abstract: BACKGROUND
  The latest generations of bisphosphonates constitute a major advance in the management of disorders including Paget's disease, osteoporosis, and osteolytic bone tumors. Recent reports describe numerous cases of osteonecrosis of the jaw in patients treated with bisphosphonates. Some of these reports mention predisposing factors, including surgical procedures, chemotherapy, and radiotherapy.
  
  
  METHODS
  In the past 12 months, we have observed and treated 9 cases of maxillary osteonecrosis, which we present summarily.
  
  
  CONCLUSIONS
  Some of our cases (3 of 9), like many of those described in literature, do not present predisposing factors. The osteonecrosis may thus be due mainly to the effect of bisphosphonates that, by blocking bone remodeling, may cause excessive bone mineralization. If this hypothesis is confirmed, these cases of osteonecrosis may be due to excess doses. Better dose adjustment should thus help prevent this complication.
authors.affiliation: Division de stomatologie, chirurgie orale et radiologie dentomaxillo-faciale, Faculté de Médecine, Genève. abns77@hotmail.com
authors.forename: S
authors.initials: S
authors.lastname: Abi Najm
authors.forename: S
authors.initials: S
authors.lastname: Lysitsa
authors.forename: J P
authors.initials: JP
authors.lastname: Carrel
authors.forename: P
authors.initials: P
authors.lastname: Lesclous
authors.forename: T
authors.initials: T
authors.lastname: Lombardi
authors.forename: J
authors.initials: J
authors.lastname: Samson
mesh_terms: D000293:Adolescent; D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D007571:Jaw Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D000077268:Pamidronate; D011862:Radiography, Panoramic; D011877:Radionuclide Imaging; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate